This is a textbook bullish cluster — C-suite, board, and 10% owners all buying heavily at the same price on the same day. The $18.00/share level now acts as a strong floor. Traders should watch for a potential catalyst (e.g., positive Phase 2/3 data, partnership, or NDA submission) that the insiders may be anticipating.
Price Chart
Executive Summary
A massive insider buying cluster at Braveheart Bio, Inc. (BRVE) saw 10 insiders — including the CEO, CFO, Chief Development Officer, multiple directors, and three 10% owners — collectively purchase ~$114.6M worth of stock on August 7, 2026, all at $18.00/share. This is the largest insider buying cluster by dollar value seen in recent months, representing approximately 6.4% of the company's $1.8B market cap, and is a powerful bullish signal. The cluster is amplified by concurrent derivative conversions (non-cash) from several of the same insiders, suggesting a coordinated re-investment in the company's equity ahead of a potential catalyst.
Key Financial Metrics
Key Facts
- 10 insiders purchased shares on August 7, 2026, all at $18.00/share.
- Total open-market purchases: ~$114.6M, representing ~6.4% of BRVE's $1.8B market cap.
- CEO Travis Murdoch purchased $1.5M worth of shares.
- CFO James Paul Rickey purchased $500K worth of shares.
- Three 10% owners (OrbiMed Advisors, AH Bio Fund IV, Forbion Growth Opportunities Fund III) participated, with OrbiMed alone buying ~$35M.
- Multiple insiders also converted derivatives (non-cash transactions) on the same day, indicating a coordinated equity re-investment.
- The cluster is amplified by cross-filing context showing no recent negative filings (no late filing, no restatement, no offering).
- The total value of the cluster exceeds the 2% of market cap threshold for 'highly material' insider activity.
Financial Impact
~$114.6M in open-market purchases, ~6.4% of market cap
Risk Factors
- Insiders could be buying to support the stock price ahead of a dilutive offering (though no offering is in the cross-filing context).
- The cluster is concentrated on a single day — if the catalyst fails to materialize, the stock could drift back toward pre-cluster levels.
- The $18.00 price point may be a negotiated block trade price, not a true market price, limiting the signal's precision.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BRVE-1786521785287 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 3 | $27.66 $26.71 | ▼ −3.43% | ▼ −1.46% | $21.87 (−20.93%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.87 (−16.37%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.87 (−16.37%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.87 (−20.56%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.87 (−20.56%) |
Aug 5, 2026 11w ago | Press Release | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers